Skip to main content
Premium Trial:

Request an Annual Quote

Ian Clark

Guardant Health has appointed Ian Clark to its board of directors. Clark joins Guardant Health from Genetech, where he served as CEO, and Roche, where he led North American commercial operations. He has also held leadership roles at Novartis, Sanofi, and Ivax.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.